




Searching News Database: Sirion Therapeutics
HSMN NewsFeed - 25 Oct 2007
Sirion Therapeutics Announces Positive Phase III Results for Difluprednate
Sirion Therapeutics Announces Positive Phase III Results for Difluprednate
HSMN NewsFeed - 16 Apr 2007
Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
HSMN NewsFeed - 17 Jan 2007
Sirion Therapeutics Acquires U.S. License to Develop New Treatment for Viral Eye Infection
Sirion Therapeutics Acquires U.S. License to Develop New Treatment for Viral Eye Infection
HSMN NewsFeed - 24 Jul 2006
Sirion Therapeutics Acquires U.S. License to Develop New Ophthalmic Compound
Sirion Therapeutics Acquires U.S. License to Develop New Ophthalmic Compound
HSMN NewsFeed - 22 Jun 2006
Sirion Therapeutics Acquires U.S. License to Develop New Treatment for Eye Disease
Sirion Therapeutics Acquires U.S. License to Develop New Treatment for Eye Disease
Additional items found! 1

Members Archive contains
1 additional stories matching:
Sirion Therapeutics
(Password required)
Sirion Therapeutics
(Password required)